Explore

@cancers-mdpi.bsky.social Oct 8, 2026, 6:45 AM

🧩Editor's Choice
Clinical Validity of NETest2.0® in Surveillance of #NeuroendocrineTumor Patients: Evidence from a #NET Registry Study (NCT02270567)
👥Anthony Gulati, Diane Reidy et al.
Full text➡️ www.mdpi.com/2072-6694/18...
🗝️Keywords: #biomarker; liquid biopsy; #mRNA
@dukecancer.bsky.social

Figure 2. STARD diagram showing an overview of the design, cohort selection, and outcome stratification for Objective 2. Abbreviations: IPD: image-positive disease, IND: image-negative disease; R0: margin-negative curative surgery; PD: progressive disease; SD: stable disease. Responders include stable disease (SD), partial responses (PR), and complete responses (CR). Non-responders are identified as progressive disease (PD). IQR = interquartile range.

@stemcellsciencenews.com Oct 1, 2026, 5:53 PM

Study findings in @cddpress.bsky.social identify the ESAM/Calnexin/mTOR axis as a candidate #biomarker and therapeutic vulnerability in HER2-positive #BreastCancer.

Read about the research here: https://go.nature.com/4xLUiVg

@sigtrans-sttt.bsky.social Sep 29, 2026, 4:05 PM

Traditional #Biomarker discovery suffers from single-modality analyses, weak mechanistic foundations, and low reproducibility.

This review examines #AI approaches for precision diagnostics and targeted therapies.

#STTT #OpenAccess: doi.org/10.1038/s413...
#DrugDelivery

Artificial intelligence in biomarker discovery for diseases: diagnostic and therapeutic prospects

@sigtrans-sttt.bsky.social Sep 26, 2026, 6:30 AM

The TRAINER phase II study evaluates #Biomarker-driven total #Neoadjuvant therapy with bevacizumab or cetuximab for high-risk #RectalCancer, reporting complete responses and high sphincter preservation.

#STTT #OpenAccess: doi.org/10.1038/s413...

A multicohort, biomarker-driven phase 2 trial of personalized total neoadjuvant therapy with targeted agents for high-risk rectal cancer (The TRAINER study)

@dgarmstrong.bsky.social Sep 25, 2026, 4:52 PM

When it comes to #DiabeticFoot infections, Moderate ≠ Severe: New #Biomarker Data Reignite and Support the Case for Splitting Categories #IDSA #WIfI #ActAgainstAmputation diabeticfootonline.c...

@genesndiseases.bsky.social Sep 24, 2026, 2:54 PM

Mitochondrial redox balance could reveal new cancer clues.
This pan-cancer study links SLC25A39 to tumor progression, immune checkpoints and #immunotherapy response, highlighting its #biomarker potential. #GastricCancer
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...

@sigtrans-sttt.bsky.social Sep 22, 2026, 7:15 AM

Protein #Lactylation connects cellular metabolism with #Epigenetic regulation.
This review examines its molecular machinery and functions across physiology and disease, highlighting #Biomarker and therapeutic potential.

#STTT #OpenAccess: doi.org/10.1038/s413...

Protein lactylation in health and diseases: molecular mechanisms, biological significance, and clinical implications

@toppnews.bsky.social Sep 22, 2026, 5:22 AM

#biomarker #disease #early detection #Parkinson #research
🌐 www.newsmart.ch

@toppnews.bsky.social Sep 21, 2026, 3:36 PM

#biomarker #disease #early detection #Parkinson #research
🌐 www.newsmart.ch

@molneurodegen.bsky.social Sep 21, 2026, 1:40 PM

Plasma GDF15 as a potential #biomarker and driver of #neuroinflammation and #dementia risk

José M. Izquierdo @uam.es

link.springer.com/article/10.1...

@toppnews.bsky.social Sep 20, 2026, 4:36 AM

#attack #biomarker #clinical trial #Don #evidence #Stroke
🌐 www.newsmart.ch

@genesndiseases.bsky.social Sep 20, 2026, 4:28 AM

Decoding #PancreaticCancer requires uncovering #circRNA‑driven oncogenic programs.
NSUN2‑mediated circSMAD2 promotes tumor growth via ceRNA and m6A regulation, activating AKT/mTOR and emerging as a #biomarker and therapeutic target.
#GenesAndDiseases: doi.org/10.1016/j.ge...

@toppnews.bsky.social Sep 19, 2026, 10:54 AM

#attack #biomarker #clinical trial #Don #evidence #Stroke
🌐 www.newsmart.ch

@intjextremmanuf.bsky.social Sep 18, 2026, 1:30 PM

Electroactive bio-#Microneedles integrate sensing and therapy through responsive biointerfaces, enabling #Biomarker monitoring, controlled #DrugDelivery, electrostimulation, and closed-loop healthcare.

#IJEM #OpenAccess: doi.org/10.1088/2631...

Emerging electroactive bio-microneedles for innovative minimally invasive theranostic applications

@fiosgenomics.bsky.social Sep 17, 2026, 3:30 PM

#Biomarker validation is crucial, misuse can lead to false results and poor outcomes.
Learn more about biomarkers validation in our blog: https://www.fiosgenomics.com/biomarker-validation-avoiding-misleading-results
#bioinformatics #drugdevelopment

@abseabio.bsky.social Sep 16, 2026, 2:00 PM

pTau217 is a core AD blood #biomarker. What can other tau phosphorylation sites add?

Brain-tissue studies suggest pSer396 rises mainly at later Braak stages, alongside more widespread cortical tau pathology.

Absea’s #pTau396 pairs are evaluated using protein standards and biological samples. 🧪

@genesndiseases.bsky.social Sep 13, 2026, 3:06 PM

Learn how a #lncRNA fuels #ColorectalCancer.
This study identifies AC004854.2 as a driver of c-MYC transcription through the SOX4/AC004854.2/PUF60 axis, highlighting a promising #biomarker and therapeutic target beyond WNT/β-catenin.
#GenesAndDiseases: doi.org/10.1016/j.ge...